{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,4]],"date-time":"2026-04-04T09:52:41Z","timestamp":1775296361553,"version":"3.50.1"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2018,12,5]],"date-time":"2018-12-05T00:00:00Z","timestamp":1543968000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100004366","name":"Tabriz University of Medical Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004366","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["World J Pediatr"],"published-print":{"date-parts":[[2019,4]]},"DOI":"10.1007\/s12519-018-0217-8","type":"journal-article","created":{"date-parts":[[2018,12,5]],"date-time":"2018-12-05T01:07:07Z","timestamp":1543972027000},"page":"135-142","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Effect of metoclopramide administration to mothers on neonatal bilirubin and maternal prolactin: a randomized, controlled, clinical trial"],"prefix":"10.1007","volume":"15","author":[{"given":"Shirin Osouli","family":"Tabrizi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mojgan","family":"Mirghafourvand","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abdollah Jannat","family":"Dost","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sakineh","family":"Mohammad-Alizadeh-Charandabi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yousef","family":"Javadzadeh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robabe","family":"Seyedi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,12,5]]},"reference":[{"key":"217_CR1","doi-asserted-by":"publisher","first-page":"e0117229","DOI":"10.1371\/journal.pone.0117229","volume":"10","author":"BO Olusanya","year":"2015","unstructured":"Olusanya BO, Osibanjo FB, Slusher TM. Risk Factors for severe neonatal hyperbilirubinemia in low and middle-income countries: a systematic review and meta-analysis. PLoS One. 2015;10:e0117229.","journal-title":"PLoS One"},{"key":"217_CR2","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1056\/NEJM200102223440807","volume":"344","author":"PA Dennery","year":"2001","unstructured":"Dennery PA, Seidman DS, Stevenson DK. Neonatal hyperbilirubinemia. N Engl J Med. 2001;344:581\u201390.","journal-title":"N Engl J Med"},{"key":"217_CR3","doi-asserted-by":"publisher","first-page":"e47","DOI":"10.1542\/peds.110.4.e47","volume":"110","author":"M Kaplan","year":"2002","unstructured":"Kaplan M, Muraca M, Hammerman C, Rubaltelli FF, Vilei MT, Vreman HJ, et al. Imbalance between production and conjugation of bilirubin: a fundamental concept in the mechanism of neonatal jaundice. Pediatrics. 2002;110:e47.","journal-title":"Pediatrics"},{"key":"217_CR4","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/S1875-9572(10)60027-7","volume":"51","author":"RS Cohen","year":"2010","unstructured":"Cohen RS, Wong RJ, Stevenson DK. Understanding neonatal jaundice: a perspective on causation. Pediatr Neonatol. 2010;51:143\u20138.","journal-title":"Pediatr Neonatol."},{"key":"217_CR5","doi-asserted-by":"publisher","first-page":"E17","DOI":"10.1542\/peds.106.2.e17","volume":"106","author":"VK Bhutani","year":"2000","unstructured":"Bhutani VK, Gourley GR, Adler S, Kreamer B, Dalin C, Johnson LH. Noninvasive measurement of total serum bilirubin in a multiracial predischarge newborn population to assess the risk of severe hyperbilirubinemia. Pediatrics. 2000;106:E17.","journal-title":"Pediatrics"},{"key":"217_CR6","doi-asserted-by":"publisher","first-page":"920","DOI":"10.1056\/NEJMct0708376","volume":"358","author":"MJ Maisels","year":"2008","unstructured":"Maisels MJ, McDonagh AF. Phototherapy for neonatal jaundice. N Engl J Med. 2008;358:920\u20138.","journal-title":"N Engl J Med"},{"key":"217_CR7","first-page":"0319","volume":"2015","author":"P Woodgate","year":"2015","unstructured":"Woodgate P, Jardine LA. Neonatal jaundice: phototherapy. BMJ Clin Evid. 2015;2015:0319.","journal-title":"BMJ Clin Evid."},{"key":"217_CR8","doi-asserted-by":"publisher","first-page":"976","DOI":"10.1016\/j.arcped.2014.02.005","volume":"21","author":"A Cortey","year":"2014","unstructured":"Cortey A, Elzaabi M, Waegemans T, Roch B, Aujard Y. Efficacy and safety of intravenous immunoglobulins in the management of neonatal hyperbilirubinemia due to ABO incompatibility: a meta-analysis. Arch Pediatr. 2014;21:976\u201383 (in French).","journal-title":"Arch Pediatr"},{"key":"217_CR9","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1053\/siny.2002.0098","volume":"7","author":"PA Dennery","year":"2002","unstructured":"Dennery PA. Pharmacological interventions for the treatment of neonatal jaundice. Semin Neonatol. 2002;7:111\u20139.","journal-title":"Semin Neonatol."},{"key":"217_CR10","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1542\/peds.114.1.297","volume":"114","author":"American Academy of Pediatrics Subcommittee on Hyperbilirubinemia","year":"2004","unstructured":"American Academy of Pediatrics Subcommittee on Hyperbilirubinemia. Management of hyperbilirubinemia in the newborn infant 35 or more weeks of gestation. Pediatrics. 2004;114:297\u2013316.","journal-title":"Pediatrics"},{"key":"217_CR11","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1177\/089033440201800311","volume":"18","author":"MP Gabay","year":"2002","unstructured":"Gabay MP. Galactogogues: medications that induce lactation. J Hum Lact. 2002;18:274\u20139.","journal-title":"J Hum Lact."},{"key":"217_CR12","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1093\/bja\/aer509","volume":"108","author":"BM Mishriky","year":"2012","unstructured":"Mishriky BM, Habib AS. Metoclopramide for nausea and vomiting prophylaxis during and after Caesarean delivery: a systematic review and meta-analysis. Br J Anaesth. 2012;108:374\u201383.","journal-title":"Br J Anaesth"},{"key":"217_CR13","unstructured":"Metoclopramide. https:\/\/www.drugbank.ca\/drugs\/DB01233 . Accessed 14 Jun 2017."},{"key":"217_CR14","doi-asserted-by":"publisher","first-page":"162","DOI":"10.18433\/J3DS3R","volume":"13","author":"AA Zuppa","year":"2010","unstructured":"Zuppa AA, Sindico P, Orchi C, Carducci C, Cardiello V, Romagnoli C. Safety and efficacy of galactogogues: substances that induce, maintain and increase breast milk production. J Pharm Pharm Sci. 2010;13:162\u201374.","journal-title":"J Pharm Pharm Sci."},{"key":"217_CR15","doi-asserted-by":"publisher","first-page":"274","DOI":"10.4097\/kjae.2012.63.3.274","volume":"63","author":"YY Jo","year":"2012","unstructured":"Jo YY, Kim YB, Yang MR, Chang YJ. Extrapyramidal side effects after metoclopramide administration in a post-anesthesia care unit\u2014a case report. Korean J Anesthesiol. 2012;63:274\u20136.","journal-title":"Korean J Anesthesiol."},{"key":"217_CR16","unstructured":"Food & Drug Administration. FDA requires boxed warning and risk mitigation strategy for metoclopramide-containing drugsagency warns against chronic use of these products to treat gastrointestinal disorders. 2009. http:\/\/www.fda.gov\/bbs\/topics\/NEWS\/2009\/NEW01963.html . Accessed 28 Feb 2017."},{"key":"217_CR17","doi-asserted-by":"publisher","first-page":"16","DOI":"10.5603\/MH.2014.0004","volume":"65","author":"E Dahl","year":"2014","unstructured":"Dahl E, Diskin AL. Long-lasting adverse effects after short-term low-dose treatment with metoclopramide for vomiting. Int Marit Health. 2014;65:16\u20139.","journal-title":"Int Marit Health."},{"key":"217_CR18","doi-asserted-by":"publisher","first-page":"53","DOI":"10.3109\/00016347909154914","volume":"58","author":"V Guzm\u00e1n","year":"1979","unstructured":"Guzm\u00e1n V, Toscano G, Canales ES, Z\u00e1rate A. Improvement of defective lactation by using oral metoclopramide. Acta Obstet Gynecol Scand. 1979;58:53\u20135.","journal-title":"Acta Obstet Gynecol Scand"},{"key":"217_CR19","first-page":"CD005544","volume":"3","author":"TJ Donovan","year":"2012","unstructured":"Donovan TJ, Buchanan K. Medications for increasing milk supply in mothers expressing breastmilk for their preterm hospitalised infants. Cochrane Database Syst Rev. 2012;3:CD005544.","journal-title":"Cochrane Database Syst Rev."},{"key":"217_CR20","first-page":"32","volume":"14","author":"E Dastgerdi","year":"2011","unstructured":"Dastgerdi E, Shirazi M, Mohammadzadeh A, Shahrarha A, Amiri R. Effect of metoclopramide on increased milk production in mothers of preterm infants. J Gyn Ir. 2011;14:32\u20136 (in Persian).","journal-title":"J Gyn Ir."},{"key":"217_CR21","doi-asserted-by":"publisher","first-page":"F241","DOI":"10.1136\/archdischild-2011-300601","volume":"97","author":"J Ingram","year":"2012","unstructured":"Ingram J, Taylor H, Churchill C, Pike A, Greenwood R. Metoclopramide or domperidone for increasing maternal breast milk output: a randomised controlled trial. Arch Dis Child Fetal Neonatal Ed. 2012;97:F241\u20135.","journal-title":"Arch Dis Child Fetal Neonatal Ed"},{"key":"217_CR22","first-page":"929","volume":"3","author":"DL Torre","year":"2007","unstructured":"Torre DL, Falorni A. Pharmacological causes of hyperprolactinemia. Ther Clin Risk Manag. 2007;3:929\u201351.","journal-title":"Ther Clin Risk Manag"},{"key":"217_CR23","first-page":"524","volume":"36","author":"A Lafuente","year":"1994","unstructured":"Lafuente A, Marco J, Esquifino AI. Opioids and the pulsatile prolactin secretory pattern: effects of hyperprolactinemia. Vet Hum Toxicol. 1994;36:524\u20138.","journal-title":"Vet Hum Toxicol"},{"key":"217_CR24","volume-title":"Breastfeeding: a guide for the medical professional","author":"R Lawrence","year":"2011","unstructured":"Lawrence R, Lawrence R. Breastfeeding: a guide for the medical professional. 7th ed. Philadelphia: Saunders; 2011.","edition":"7"},{"key":"217_CR25","unstructured":"Gullu S. Prolactin: an underestimated hormone. Endocrine abstracts. 2008;16:ME9. https:\/\/www.endocrine-abstracts.org\/ea\/0016\/ea0016me9 . Accessed 12 Nov 2017."},{"key":"217_CR26","first-page":"150","volume":"16","author":"R Saeidi","year":"1970","unstructured":"Saeidi R, Gholami Robatsangi M,\u00a0Mirza Rahimi M, Amiri Tehrani Zadeh M. Comparison of serum bilirubin measurement in laboratory and transcutaneous bilirubinometry. J Sabzevar Univ Med Sci. 1970;16:150\u20134 (in Persian).","journal-title":"J Sabzevar Univ Med Sci"},{"key":"217_CR27","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/0028-2243(85)90160-1","volume":"19","author":"A Kauppila","year":"1985","unstructured":"Kauppila A, Anunti P, Kivinen S, Koivisto M, Ruokonen A. Metoclopramide and breast feeding: efficacy and anterior pituitary responses of the mother and the child. Eur J Obstet Gynecol Reprod Biol. 1985;19:19\u201322.","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"217_CR28","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1097\/01.AOG.0000151113.33698.a8","volume":"105","author":"WF Hansen","year":"2005","unstructured":"Hansen WF, McAndrew S, Harris K, Zimmerman MB. Metoclopramide effect on breastfeeding the preterm infant: a randomized trial. Gynecol Obstet. 2005;105:383\u20139.","journal-title":"Gynecol Obstet."},{"key":"217_CR29","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1177\/0890334403252472","volume":"19","author":"M Cooke","year":"2003","unstructured":"Cooke M, Sheehan A, Schmied V. A description of the relationship between breastfeeding experiences, breastfeeding satisfaction, and weaning in the first 3\u00a0months after birth. J Hum Lact. 2003;19:145\u201356.","journal-title":"J Hum Lact."},{"key":"217_CR30","doi-asserted-by":"crossref","first-page":"55","DOI":"10.22543\/2392-7674.1011","volume":"2","author":"E \u0218tef\u0103nescu","year":"2015","unstructured":"\u0218tef\u0103nescu E, Ple\u0219u M, Scutari C, Junghin\u0103 A, Mire\u0219an H. Metoclopramide neurological side effects screening; a pharmacovigilence study in Romanian community pharmacies. J Mind Med Sci. 2015;2:55\u201366.","journal-title":"J Mind Med Sci."},{"key":"217_CR31","doi-asserted-by":"publisher","first-page":"1175","DOI":"10.1016\/S0140-6736(81)92347-3","volume":"1","author":"A Kauppila","year":"1981","unstructured":"Kauppila A, Kivinen S, Ylikorkala O. A dose response relation between improved lactation and metoclopramide. Lancet. 1981;1:1175\u20137.","journal-title":"Lancet"}],"container-title":["World Journal of Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12519-018-0217-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12519-018-0217-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12519-018-0217-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,4]],"date-time":"2026-04-04T09:07:02Z","timestamp":1775293622000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12519-018-0217-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,12,5]]},"references-count":31,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2019,4]]}},"alternative-id":["217"],"URL":"https:\/\/doi.org\/10.1007\/s12519-018-0217-8","relation":{},"ISSN":["1708-8569","1867-0687"],"issn-type":[{"value":"1708-8569","type":"print"},{"value":"1867-0687","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,12,5]]},"assertion":[{"value":"12 July 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 November 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 December 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical statements"}},{"value":"This study was approved by the Ethics Committee of the Research and Technology Deputy of Tabriz University of Medical Sciences (IR.TBZMED.REC.1395.1020). Written informed consent was obtained from all individual participants included in the study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"No financial or nonfinancial benefits have been received or will be received from any party related directly or indirectly to the subject of this article.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}